GINGER POWERS: Open Payments
NPI 1659872000 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 27 payments from 5 companies in 2025. Trend: 2023 $69 · 2024 $462 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $381 |
| PFIZER INC. | 4 | $77 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| TerSera Therapeutics LLC | 1 | $19 |
Products named: UBRELVY, QULIPTA, NURTEC ODT, Symbravo, AJOVY, Prialt, BOTOX.
Industry payments across ID — which companies pay providers there.
